Clinical Study On Treatment Of Functional Dyspepsia Discomfort Syndrome (Liver Stagnation And Spleen Deficiency Syndrome) With

Object:Observation of Heweixiaopi Decoction in the treatment of functional dyspepsia with postprandial distress integrated short-term and long-term effect of patient with liver stagnation and spleen deficiency syndrome, aims to explore the new methods of traditional Chinese medicine in the treatment of functional dyspepsia.Method:The clinic of digestive department of our hospital with functional dyspepsia postprandial distress syndrome of stagnation of liver and spleen deficiency syndrome diagnosis in100patients, according to the randomized digital table were randomly divided into treatment group and control group:.50cases in the treatment group, treated with Heweixiaopi Decoction orally,3times a day, each time100ml after meals; control group of50cases:with Weisu granule5g/time,3times/day, Jianpi ginseng tablets4tablets each time,2times/day, after oral administration. The course of treatment was4weeks,4weeks of follow-up, quantization and record the symptom score, statistical processing and analysis using SPSS17.0software to collect data, draw a conclusion.Results:1. The total effect of the two groups:the treatment group cured29cases, effective in10cases, effective5cases, invalid6cases,.the total efficiency of88%, control group25cases were cured,8cases markedly effective,6cases,11cases ineffective, the total efficiency of78%. Confidence intervals overlap method in Ritid analysis, two groups of95%CI overlap, there was no significant difference in. But R treatment<R control, group two level from "good" to "bad" arrangement, show the efficacy of the treatment group is better than control group. 2. Two groups of TCM syndrome integral lower values, the difference was statistically significant (P<0.05), showed that the treatment group than the control group.3. Comparison of the onset time of the two groups, there was statistically significant at first week,2week,3week of TCM syndrome integral differential (P<0.05), showed that in the treatment group, the onset speed faster than the control group.4. The severity of disease:two groups of patients with mild total efficiency is100%, the treatment group to moderate cases the total efficiency is79.17%, control group59.09%; show that the two groups of patients with mild to moderate, have better effect. Two groups of patients with severe cases are less, can not illustrate the effect.4. Comparison of two treatment group total symptoms after1weeks of integration, the difference was statistically significant (P<0.05), treatment group total symptom score lower, that the effects of treatment group after treatment for1weeks significantly.5. Compared before and after treatment the symptom integral group: except the control group there was no significant difference in insomnia symptoms (P>0.05), there was significant difference between two groups in other single symptom (P<0.05). Groups after treatment, symptom comparison:improve the difference between the two groups has statistical significance in insomnia, belch hiccup, good Taixi or irritability and other symptoms (P<0.05), showed that the treatment group is better than the treatment group.6. The treatment group of3cases relapsed within1months, the recurrence rate was6.82%,10cases of control group of recurrence, the recurrence rate was25.64%, the difference was statistically significant (P<0.05), showed that the relapse rate in treatment group was lower than the control group. Conclusion:This study shows that Heweixiaopi Decoction in the treatment of functional dyspepsia with postprandial distress syndrome of stagnation of liver qi and deficiency of spleen of good, fast acting, notable for eructation hiccups, insomnia, good Taixi or irritability symptoms within1months, the recurrence rate is low, is worthy of further popularization and application.